The effect of sitagliptin on postprandial lipoprotein metabolism in patients with diabetes mellitus type 2.

Trial Profile

The effect of sitagliptin on postprandial lipoprotein metabolism in patients with diabetes mellitus type 2.

Discontinued
Phase of Trial: Phase IV

Latest Information Update: 24 Mar 2012

At a glance

  • Drugs Sitagliptin (Primary) ; Glimepiride
  • Indications Type 2 diabetes mellitus
  • Focus Pharmacodynamics
  • Most Recent Events

    • 24 Jun 2011 Planned end date changed from Dec 2011 to May 2011 as reported by ClinicalTrials.gov.
    • 24 Jun 2011 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov.
    • 25 Jan 2011 Planned End Date changed from 1 Jul 2011 to 1 Dec 2011 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top